ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEE....SK................*JDIM350 (Ver 2.1 Jan 2001) 2999001/01434570CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120051026W10000000073DEBibliographieENBibliographyFRBibliographieEP02775048.82002093020040323enenen012445520011011GB20051026200543200407072004282005083120053520050216200510262005437 7A 61K 9/22 A 7A 61K 9/52 B 7A 61K 31/517 B 7A 61P 13/08 BdePHARMAZEUTISCHE FORMULIERUNGEN ZUR GESTEUERTEN FREISETZUNG VON 4-AMINO-6,7-DIMETHOXY-2-(5-METHANESULFONAMIDO-1,2,3,4-TETRAHYDROISOCHINOL-2-YL)-5-(2-PYRIDYL)CHINAZOLINenPHARMACEUTICAL FORMULATIONS FOR THE CONTROLLED RELEASE OF 4-AMINO-6,7-DIMETHOXY-2-(5-METHANESULFONAMIDO-1,2,3,4-TETRAHYDROISOQUINOL-2-YL)-5-(2-PYRIDYL)QUINAZOLINEfrFORMULATIONS PHARMACEUTIQUES DESTINEES A LA LIBERATION CONTROLEE DE 4-AMINO-6,7-DIMETHOXY-2-(5-METHANESULFONAMIDO-1,2,3,4-TETRAHYDROISOQUINOL-2-YL)-5-(2-PYRIDYL) QUINAZOLINEEP-A- 0 466 986EP-A- 1 123 705WO-A-01/64672WO-A-98/30560FR-A- 2 752 737DAVIS, John, D., Pfizer Global Research and Dev.Ramsgate RoadSandwich, Kent CT13 9NJGBHUMPHREY, Michael, J., Pfizer Global Rch. and Dev.Ramsgate RoadSandwich, Kent CT13 9NJGBMACRAE, Ross, J., Pfizer Global Research and Dev.Ramsgate RoadSandwich, Kent CT13 9NJGBSMITH, Janet, S., Pfizer Global Research and Dev.Ramsgate RoadSandwich, Kent CT13 9NJGBPfizer Limited00204310PC10964ARamsgate RoadSandwich, Kent CT13 9NJGBGBPFIZER INC.00200961PC10964A235 East 42nd StreetNew York, N.Y. 10017USATBEBGCHCYCZDEDKEEESFIFRGRIEITLUMCNLPTSESKTRBridle, Andrew Barry00095242Pfizer Limited UK Patent Department Ramsgate RoadSandwich, Kent CT13 9NJGBATBEBGCHCYCZDEDKEEESFIFRGBGRIEITLILUMCNLPTSESKTRAL20040323LT20040323LV20040323MK20040323RO20040323SI20040323IB200200404020020930enWO200303295620030424200317